MetLife Files 8-K for Regulation FD Disclosure
Ticker: MET · Form: 8-K · Filed: Apr 7, 2026 · CIK: 0001099219
| Field | Detail |
|---|---|
| Company | Metlife Inc (MET) |
| Form Type | 8-K |
| Filed Date | Apr 7, 2026 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 M, $475 million, $525 million, $1.6 billion |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, disclosure, filing
TL;DR
MetLife dropped an 8-K on 4/7/26 for Reg FD. Standard disclosure stuff.
AI Summary
MetLife Inc. filed an 8-K on April 7, 2026, to disclose information under Regulation FD. The filing includes various XBRL documents related to their financial reporting. The company's principal executive offices are located at 200 Park Avenue, New York, NY 10166.
Why It Matters
This filing serves as a public announcement of information that MetLife Inc. is required to disclose to maintain fair and transparent communication with investors.
Risk Assessment
Risk Level: low — This is a routine regulatory filing with no new material financial events or changes in business operations disclosed.
Key Players & Entities
- METLIFE INC (company) — Filer
- 0001099219 (company) — CIK number for MetLife Inc.
- 200 PARK AVENUE NEW YORK NY 10166 (location) — Mailing and Business Address
- 212-578-5500 (phone_number) — Business Phone Number
- 2026-04-07 (date) — Filing Date
FAQ
What is the purpose of this 8-K filing?
The purpose of this 8-K filing is for MetLife Inc. to disclose information under Regulation FD.
When was this 8-K filing accepted by the SEC?
This 8-K filing was accepted by the SEC on April 7, 2026.
What is MetLife Inc.'s CIK number?
MetLife Inc.'s CIK number is 0001099219.
Where are MetLife Inc.'s principal executive offices located?
MetLife Inc.'s principal executive offices are located at 200 Park Avenue, New York, NY 10166.
What type of company is MetLife Inc. primarily involved in, according to its SIC code?
According to its SIC code (6311), MetLife Inc. is primarily involved in Life Insurance.
Filing Stats: 821 words · 3 min read · ~3 pages · Grade level 12.3 · Accepted 2026-04-07 06:05:59
Key Financial Figures
- $0.01 M — ich registered Common Stock, par value $0.01 MET New York Stock Exchange Floating Rat
- $475 million — investment income will be approximately $475 million to $525 million (pre-tax), which compar
- $525 million — e will be approximately $475 million to $525 million (pre-tax), which compares to full-year
- $1.6 billion — ull-year 2026 guidance of approximately $1.6 billion (pre-tax). Variable investment income i
Filing Documents
- met-20260407.htm (8-K) — 31KB
- 0001099219-26-000019.txt ( ) — 193KB
- met-20260407.xsd (EX-101.SCH) — 2KB
- met-20260407_def.xml (EX-101.DEF) — 16KB
- met-20260407_lab.xml (EX-101.LAB) — 29KB
- met-20260407_pre.xml (EX-101.PRE) — 17KB
- met-20260407_htm.xml (XML) — 6KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. MetLife, Inc. (the "Company") is furnishing this Current Report on Form 8-K to disclose preliminary information regarding variable investment income prior to the availability of the Company's quarterly earnings release and quarterly financial supplement for the quarter ended March 31, 2026, scheduled for release on May 6, 2026. Based on preliminary results received to date, for the quarter ended March 31, 2026, the Company estimates that its variable investment income will be approximately $475 million to $525 million (pre-tax), which compares to full-year 2026 guidance of approximately $1.6 billion (pre-tax). Variable investment income includes private equity, real estate and other funds and prepayment fees. The preliminary financial information presented above for the quarter ended March 31, 2026, is estimated and unaudited and has been prepared in good faith on a basis consistent with prior periods based on information available to management as of the date hereof; however, we have not completed our financial closing procedures for the quarter ended March 31, 2026, and our actual results could be materially different from these preliminary financial results. As a result, prospective investors should exercise caution in relying on this information and should not draw any inferences from this information regarding financial or operating data not provided. These preliminary financial results should not be viewed as a substitute for full financial statements prepared in accordance with U.S. GAAP. In addition, these preliminary financial results are not necessarily indicative of the results to be achieved in any future period. The forward-looking statements in this disclosure, which use terms such as "estimates," "guidance," "preliminary," and "will," are based on assumptions and expectations that involve risks and uncertainties, including the "Risk Factors" MetLife, Inc. describes in its U.S. Securities and Exchange Commission
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. METLIFE, INC. By: /s/ Adrienne O'Neill Name: Adrienne O'Neill Title: Executive Vice President and Chief Accounting Officer Date: April 7, 2026 3